A critical shortage of essential medicines is gripping Northern Ireland, leaving pharmacists struggling to keep shelves stocked and patients facing uncertainty.
Pharmacies across Northern Ireland are sounding the alarm about a widening gap in the availability of crucial medications, with prescription-strength co-codamol being a prime example. Community Pharmacy NI (CPNI) has issued a stark warning: this shortage isn't a fleeting issue; it's expected to persist for several months. To ensure that patients receive at least some supply and don't run out completely, pharmacies might be compelled to implement rationing measures.
To give you a sense of scale, Northern Ireland dispenses approximately 50,000 packs, translating to about five million tablets, of co-codamol every single month. This is for a population of less than two million people – a significant amount of medication for a relatively small population.
In response to the growing crisis, the Department of Health (DoH) has taken steps, adding co-codamol to a list of medicines that cannot be hoarded or exported from the UK. This aims to keep essential supplies within the country.
Gerard Greene, the chief executive of CPNI, highlighted the immense strain community pharmacies are under. He explained that they are facing "sustained and increasing pressure", not only from the widening disparity between medicine costs and reimbursement but also from difficulties in paying wholesaler bills and securing adequate supplies to meet patient demand.
But here's where it gets particularly concerning for local pharmacies... Representatives from CPNI recently informed MLAs at Stormont that community pharmacies are actively trying to source over 100 different common medicine lines that are currently in short supply. This means patients could experience delays in receiving their prescriptions, get interim or reduced supplies, or even be referred for alternative treatments. This, in turn, places an additional workload on pharmacies and escalates the pressure on GP practices and out-of-hours services.
Greene pointed out that while medicine supply chain instability is a UK-wide concern, it's a "particular concern" for Northern Ireland due to its smaller market size and higher logistical costs compared to Great Britain. He noted that while medicine shortages have been a recurring issue in both Northern Ireland and the UK, there has been a "sharp increase" in the number of affected medicines. Common medications like prescription co-codamol and low-dose aspirin are among those experiencing these shortages, meaning a large number of people are likely to be impacted.
CPNI is urging the health minister and the executive to collaborate with the UK government to bolster medicine security and supply for Northern Ireland. A key proposal is to ensure that medicine stock is "appropriately ring-fenced" to guarantee patients continue to receive their necessary medications.
And this is the part most people miss: the potential long-term consequences. Greene warned that if these issues aren't addressed, Northern Ireland risks becoming a "lower-priority market for medicine wholesalers". This could have "serious implications for patient safety, continuity of care, and the resilience of the wider health system." He cautioned that without action, shortages will become a more frequent occurrence.
Greene appealed to the public for patience, acknowledging that pharmacy teams are "doing their best under what are very difficult circumstances." He explained that rationing might involve dispensing a month's supply at a time for a medication prescribed for several months, or if a medicine is entirely unavailable, patients may need to return to their GP for a different prescription. He strongly advised against patients self-selecting alternative medicines or altering their prescribed doses without professional medical guidance.
Danny Donnelly MLA, chair of the All-Party Group on Community Pharmacy, echoed these concerns, calling the warning "very concerning" and urging the health minister to recognize the "severity of this issue" and work with the community pharmacy sector to mitigate the risks to patients.
The Department of Health acknowledged the current supply issue with co-codamol 30/500mg tablets, stating it affects "all parts of the United Kingdom" and is indeed "concerning for patients and the healthcare professionals." They are working with the Department of Health and Social Care (DHSC) and the local health service to ensure continued access to appropriate treatments. The DoH also advised the public to continue ordering medicines in advance according to their GP practice's policy and to avoid stockpiling, as this can further strain the supply chain.
What are your thoughts on this escalating medicine shortage? Do you believe the current measures are sufficient to protect Northern Ireland's medicine supply, or are we heading towards a crisis? Share your views in the comments below!
